Phathom Pharmaceuticals (PHAT) EBT (2018 - 2026)
Phathom Pharmaceuticals' (PHAT) quarterly EBT came in at -$48.0 million in Q1 2026, up 49.13% year-on-year from -$32.2 million in Q1 2025, and down 126.89% on a QoQ basis from -$21.1 million in Q4 2025.
Phathom Pharmaceuticals (PHAT) EBT (2018 - 2026) Analysis & Trends
Phathom Pharmaceuticals (PHAT) has 9 years of EBT data on file, last reported at -$48.0 million in Q1 2026.
- On a quarterly basis, EBT rose 49.13% year-over-year to -$48.0 million in Q1 2026; TTM through Mar 2026 was -$207.7 million, a 45.18% increase from a year earlier, with the FY2025 full-year figure at -$233.5 million, up 54.9% from the prior year.
- EBT for Q1 2026 stood at -$48.0 million, down from -$21.1 million in the prior quarter.
- Over the last five years, EBT for PHAT reached as high as -$21.1 million in Q4 2025 and fell as low as -$118.7 million in Q3 2024.
- Historically, EBT has averaged -$64.0 million across 5 years, with a median of -$51.1 million in 2022.
- Across the five-year window, EBT plunged 175.73% in 2024 and soared 71.62% in 2025, its largest moves.
- Year by year, EBT stood at -$49.2 million in 2022, then tumbled by 103.99% to -$100.3 million in 2023, then rose by 25.7% to -$74.5 million in 2024, then surged by 71.62% to -$21.1 million in 2025, then plunged by 126.89% to -$48.0 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$48.0 million in Q1 2026, -$21.1 million in Q4 2025, and -$55.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Phathom Pharmaceuticals | 945.22 Mn | 761.46 Mn | 46.31 Mn | -47.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -47.97 Mn |
| Dec 31, 2025 | -21.14 Mn |
| Sep 30, 2025 | -55.21 Mn |
| Jun 30, 2025 | -83.42 Mn |
| Mar 31, 2025 | -94.29 Mn |
| Dec 31, 2024 | -74.50 Mn |
| Sep 30, 2024 | -118.69 Mn |
| Jun 30, 2024 | -91.44 Mn |
| Mar 31, 2024 | -82.81 Mn |
| Dec 31, 2023 | -100.27 Mn |
| Sep 30, 2023 | -43.05 Mn |
| Jun 30, 2023 | -46.29 Mn |
| Mar 31, 2023 | -37.83 Mn |
| Dec 31, 2022 | -49.16 Mn |
| Sep 30, 2022 | -51.08 Mn |
| Jun 30, 2022 | -50.92 Mn |
| Mar 31, 2022 | -40.70 Mn |
| Dec 31, 2021 | -36.91 Mn |
| Sep 30, 2021 | -63.72 Mn |
| Jun 30, 2021 | -69.91 Mn |